0001193125-18-132618.txt : 20181219 0001193125-18-132618.hdr.sgml : 20181219 20180426061102 ACCESSION NUMBER: 0001193125-18-132618 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20180426 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Taiwan Liposome Company, Ltd. CENTRAL INDEX KEY: 0001722890 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: F5 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 2F, 3 YUANQU STREET STREET 2: NANGANG DISTRICT CITY: TAIPEI CITY STATE: F5 ZIP: 11503 BUSINESS PHONE: 886 2 2655 7377 MAIL ADDRESS: STREET 1: 2F, 3 YUANQU STREET STREET 2: NANGANG DISTRICT CITY: TAIPEI CITY STATE: F5 ZIP: 11503 CORRESP 1 filename1.htm CORRESP

Cantor Fitzgerald & Co.

499 Park Avenue

New York, New York 10022

April 26, 2018

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Attn: Jeff Gabor

 

Re: Withdrawal of Request for Acceleration of Effective Date
  Taiwan Liposome Company, Ltd.
  Registration Statement on Form F-1 (File No. 333-223090)

Ladies and Gentlemen:

On April 23, 2018, we, as representative of the several underwriters, filed a letter with the Securities and Exchange Commission via EDGAR requesting, pursuant to Rule 461 under the Securities Act of 1933, as amended, the acceleration of the effective date of the above-referenced Registration Statement on Form F-1 (File No. 333-223090) so that it may be declared effective at 4:00 PM, Eastern Time, on April 25, 2018, or as soon thereafter as practicable. We hereby withdraw such acceleration request.

[Signature Page Follows]

Very truly yours,

CANTOR FITZGERALD & CO.

 

Acting on behalf of itself and the

several underwriters

  CANTOR FITZGERALD & CO.
By:  

/s/ Sage Kelly

  Name: Sage Kelly
  Title: Head of Investment Banking

[Signature Page to Underwriters’ Withdrawal of Acceleration Request]